ODG by MCG has adopted updates to its ODG Drug Formulary for workers' compensation, which includes U.S. Food and Drug Administration (FDA) approved drugs listed by generic and/or brand names that are commonly prescribed for workplace injuries. The changes to Appendix A of the formulary can be categorized in one of three ways: new entry, updated entry, or removed entry. All the updates are effective June 27, 2025.
Several states have adopted the ODG formulary for use in their workers’ compensation systems. Examples include Indiana, Montana, and Texas, among several others. These states, to varying degrees, require some type of prior authorization for medications listed as “N” status on the ODG formulary and in some cases for medications not listed on the ODG formulary.
MyMatrixx by Evernorth will make the following changes to our formularies in accordance with the ODG updates and deadline.
If you have questions on these changes and how they will impact your program, please contact your MyMatrixx account team.
Appendix A ODG Formulary Updates
The following ODG formulary updates are effective as of June 27, 2025, and primarily affect antidepressant medications:
| New Entries | + Viibryd (vilazodone) – antidepressant – Y drug for mental health; N drug for pain treatment |
| Updated Entry | + Celexa (citalopram) – antidepressant – Y drug (previously N drug) |
| Removed Entries | + Luvox (fluvoxamine) – antidepressant – previously N drug + Savella (milnacipran) – antidepressant – previously N drug + Avandia (rosiglitazone) – antidiabetic – previously N drug + Lamictal (lamotrigine) – antiseizure medication – previously N drug + Aredia (pamidronate) – bisphosphonate – previously Y drug |
About ODG for Workers' Compensation
ODG by MCG offers highly configurable, industry-specific medical treatment and return-to-work solutions, which are used for managing workers’ compensation, disability, and auto liability claim outcomes with evidence-based, data-driven decision support.
MyMatrixx by Evernorth Actions
MyMatrixx maintains ODG-based formularies for workers' compensation drugs and will update them in accordance with the above changes. For any changes, please reach out to your MyMatrixx account team.